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3-Phosphoinositide-dependent protein kinase 1 (PDK1)
phosphorylates and activates the p70 S6 kinase in vivo and in vitro
Dario Alessi*, Mark T. Kozlowski†, Qing-Ping Weng†, Nick Morrice* 
and Joseph Avruch†
Background: The p70 S6 kinase, an enzyme critical for cell-cycle progression
through the G1 phase, is activated in vivo by insulin and mitogens through
coordinate phosphorylation at multiple sites, regulated by signaling pathways,
some of which depend on and some of which are independent of
phosphoinositide 3-kinase (PI 3-kinase). It is not known which protein kinases
phosphorylate and activate p70.
Results: Co-expression of p70 with 3-phosphoinositide-dependent protein
kinase 1 (PDK1), a protein kinase that has previously been shown to
phosphorylate and activate protein kinase B (PKB, also known as c-Akt),
resulted in strong activation of the S6 kinase in vivo. In vitro, PDK1 directly
phosphorylated Thr252 in the activation loop of the p70 catalytic domain, the
phosphorylation of which is stimulated by PI 3-kinase in vivo and is
indispensable for p70 activity. Whereas PDK1-catalyzed phosphorylation and
activation of PKB in vitro was highly dependent on the presence of
phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3), PDK1 catalyzed
rapid phosphorylation and activation of p70 in vitro, independent of the
presence of PtdIns(3,4,5)P3. The ability of PDK1 to phosphorylate p70 Thr252
was strongly dependent on the phosphorylation of the p70 noncatalytic
carboxy-terminal tail (amino acids 422–525) and of amino acid Thr412.
Moreover, once Thr252 was phosphorylated, its ability to cause activation of
the p70 S6 kinase was also controlled by the p70 carboxy-terminal tail and by
phosphorylation of p70 Ser394, and most importantly, Thr412. The overriding
determinant of the absolute p70 activity was the strong positive cooperativity
between Thr252 and Thr412 phosphorylation; both sites must be
phosphorylated to achieve substantial p70 activation.
Conclusions: PDK1 is one of the components of the signaling pathway
recruited by PI 3-kinase for the activation of p70 S6 kinase as well as of PKB,
and serves as a multifunctional effector downstream of the PI 3-kinase.
Background
The p70 S6 kinase is the enzyme in mammalian cells
responsible for insulin-stimulated and mitogen-stimulated
phosphorylation of the 40S ribosomal protein S6, which
remains its only well-recognized substrate [1]. The two
isoforms of the enzyme, denoted α1 and α2, are produced
from a single gene by alternative mRNA splicing and the
use of an alternative translational start site [2]. The 525
amino-acid p70α1 isoform differs from the 502 amino-acid
p70α2 isoform only at the amino terminus (Figure 1),
where p70α1 contains a unique 23 amino-acid segment
that encodes a polybasic nuclear-localization motif consist-
ing of six consecutive arginine residues immediately after
the initiator methionine residue (denoted MR6 in Figure
1); this segment is also responsible for the aberrantly slow
mobility of the α1 isoform upon SDS–polyacrylamide gel
electrophoresis, so that p70α1 is sometimes called p85 S6
kinase. The cytosolic p70α2 isoform starts at a methionine
residue equivalent to Met24 in p70α1, and the sequences
of both isoforms are identical thereafter. The kinase is
highly conserved in species from mammals to Drosophila
[3,4], and its importance is indicated by the ability of anti-
p70 antibodies, microinjected into REF52 cells, to arrest
cell-cycle progression in G1 [5,6].
It has been long established that the p70 kinase is acti-
vated in vivo through phosphorylation of serine and/or
threonine residues. The enzyme undergoes a multisite
phosphorylation in response to stimulation by insulin or
mitogens in vivo; the nuclear p70α1 and cytosolic p70α2
isoforms have identical sites of phosphorylation, and avail-
able data suggest that the mechanism of activation of the
two proteins is identical. Treatment of the purified, active
enzyme with protein (serine/threonine) phosphatase in
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vitro results in complete inactivation [7,8], but reactivation
in vitro by phosphorylation has not been accomplished
previously. It now appears likely that the difficulty in
achieving reactivation arises in large part because p70 acti-
vation requires a complex array of separate, concurrent
phosphorylations at multiple sites, catalyzed by several
protein kinases.
Early work focused on a cluster of four or five serine–
proline or threonine–proline phosphorylation sites situated
in a psuedosubstrate autoinhibitory domain in the p70 non-
catalytic carboxy-terminal tail (Figure 1); phosphorylation
of these sites was predicted to release the p70 kinase from
inhibition [9]. All of these residues are rapidly phosphory-
lated upon p70 activation [10]; mutation of four of these
serine/threonine residues to alanine reduces p70 activation
in vivo by over 80%, whereas conversion to aspartate and
glutamate produces a modest increase in basal p70 activity
[11]. These serine–proline/threonine–proline sites can be
phosphorylated in vitro by an array of proline-directed
kinases that are activated by insulin or mitogen [12]; such
kinases include mitogen-activated protein (MAP) kinases,
stress-activated protein (SAP) kinases and the cyclin-
dependent kinase Cdc2; phosphorylation by these kinases,
however, fails to reactivate phosphatase 2A-treated p70 S6
kinase [13], indicating that phosphorylation of the p70
pseudosubstrate autoinhibitory domain, although perhaps
necessary, is not sufficient for p70 activation.
A further indication that phosphorylation sites critical to
p70 activation reside outside the p70 carboxy-terminal tail
comes from the observation that a p70 truncation mutant
lacking the entire carboxy-terminal tail (p70∆CT104),
when stably expressed in NIH 3T3 cells, has a low basal
activity in serum-deprived cells but undergoes a brisk,
phosphorylation-dependent activation in response to
serum that is nearly identical to that of the endogenous
full-length p70 S6 kinase [14]. Like the wild-type full-
length p70, the activation of the p70∆CT104 truncation
mutant is strongly inhibited by various phosphoinositide
(PI) 3-kinase inhibitors. Moreover, transient co-expression
of the p70∆CT104 mutant with a recombinant, constitu-
tively active PI 3-kinase (p110*) produces a robust activa-
tion of p70∆CT104 S6 kinase activity that is not further
augmented by serum. In contrast, the full-length p70
kinase is only partially activated by co-expression with PI
3-kinase, and it can be further activated by treatment of
cells with serum. Rsk1, a protein kinase that is activated
by Ras through MAP-kinase-catalyzed phosphorylation, is
not activated at all by co-expression with PI 3-kinase [15].
These findings indicated that the full-length p70 requires
both PI 3-kinase-dependent and PI 3-kinase-independent
(possibly, Ras-dependent) signals for full activation,
whereas the p70∆CT104 truncation mutant is dependent
only on PI 3-kinase-regulated pathways. 
As to the basis for the PI 3-kinase-induced activation of
p70∆CT104, initial studies demonstrated that activation
of p70∆CT104 was accompanied by a selective increase in
the phosphorylation of Thr252, a residue that is situated
in the activation loop of the p70 catalytic domain, homolo-
gous with sites of activating phosphorylation in many
protein kinases. A threonine or a serine at this site is
absolutely required for p70 activity, regardless of the pres-
ence of potentially activating mutations elsewhere. PI 3-
kinase-stimulated phosphorylation of p70 at Thr252 is
unimpaired in an inactive p70 ATP-site mutant,
p70∆CT104 (Lys123→Met) and is therefore not catalyzed
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Figure 1
Domain structure and phosphorylation sites of
the p70 S6 kinase. Two p70 isoforms are
known, α1 and α2 [2,9]. The α1 isoform is
used in all experiments presented in this
paper. The single-letter amino-acid code is
used. Pink, the canonical catalytic domain;
blue, a 65 amino-acid segment that is similarly
situated and conserved (about 40% identity)
between p70, protein kinase C isoforms,
PKBα and PKBβ, and the Rsk amino-terminal
kinase domain [9]; green, the amino-terminal
and carboxy-terminal noncatalytic regions; red
circles, sites of proline-directed
phosphorylation. The approximate locations of
10 of the known p70 phosphorylation sites
are shown and described in the text. The
casein kinase 2 site at Ser40 does not
influence catalytic function [14] and is not
discussed further. The putative autoinhibitory
psuedosubstrate domain extends from amino-
acid 423 through to amino-acid 447 [9,12].
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by a (cis) autophosphorylation. Thr252 phosphorylation is
also not catalyzed directly by the PI 3-kinase. Neverthe-
less, Thr252 phosphorylation is inhibited by pretreatment
of cells by the PI 3-kinase inhibitor wortmannin, indicat-
ing that this residue is a target in vivo for a 3-phospho-
inositide-regulated protein kinase [15].
Considerable evidence indicates that activation of
p70∆CT104 is dependent on the phosphorylation of at
least two sites in addition to Thr252, namely Thr412 and
Ser394. Like Thr252, both Thr412 [11,16] and Ser394 [17]
are sites of mitogen-stimulated phosphorylation and are
also phosphorylated in the inactive p70 S6 kinase
(Lys123→Met) mutant in vivo; conversion of either
residue to alanine ablates p70 activity. The phosphoryla-
tion of Thr412 and of Thr252 appear to be mutually inter-
dependent in vivo; the Thr412→Ala mutant fails to
undergo any detectable Thr252 phosphorylation in vivo,
and Thr412 phosphorylation is greatly reduced, although
still detectable in this mutant (Q.-P.W., M.T.K. and J.A.,
unpublished observations). Conversion of Thr412 to a glu-
tamic acid results in an increase in basal p70 activity
[16,18], restores fully the extent of p70 activation after
mitogen treatment [16,18], and restores phosphorylation at
Thr252 at least partially (Q.-P.W., M.T.K. and J.A.,
unpublished observations); the p70∆CT104 (Thr252→Ala,
Thr412→Glu) double mutant is, nevertheless, inactive
(Q.-P.W., M.T.K. and J.A., unpublished observations).
Consequently, it is not clear from these data whether
phosphorylation at Thr412 influences kinase activity
directly, or through a necessary functional collaboration
involving Thr252 phosphorylation, or entirely through the
regulation of Thr252 phosphorylation. Moreover, although
it appears clear that phosphorylation of both sites—or the
substitution of a glutamate at residue 412—is necessary to
achieve p70 activation, it is unclear whether either alone is
sufficient to sustain p70 activity.
Mutation of Ser394 to alanine also inactivates the p70
kinase [17]. This substitution has no significant effect on
Thr252 phosphorylation, but it greatly diminishes Thr412
phosphorylation. Nevertheless, conversion of Thr412 to
glutamate does not restore activity to the Ser394→Ala
mutant, indicating that, like phosphorylation of Thr252
(and, perhaps, Thr412), Ser394 phosphorylation per se is
required for p70 activity, quite apart from the effects of
Ser394 phosphorylation on Thr412 phosphorylation and
regardless of the state of Thr252 phosphorylation [17].
The properties of the Ser394→Ala mutant also establish
that Thr252 phosphorylation can occur independent of
Thr412 phosphorylation.
As regards the identity of the kinases that catalyze the
phosphorylation of these three crucial sites, a pertinent
observation is that the phosphorylation of Thr412, like that
of Thr252, is increased by co-expression with activated 
PI 3-kinase (p110*) and inhibited by wortmannin. Both
threonine residues are situated in relatively hydrophobic
contexts (...VTHT252FCGT...; ...FLGFT412YVAP..., in the
single-letter amino-acid code). Nevertheless, it is not clear
whether these two threonine residues are phosphorylated
by a single, or by two different, 3-phosphoinositide-depen-
dent protein kinases. In contrast, Ser394, like the phospho-
rylation sites in the autoinhibitory psuedosubstrate
domain, is followed directly by a proline residue and is
likely to be phosphorylated by a proline-directed kinase
distinct from the kinases acting on Thr252 and Thr412. In
summary, although deletion of the p70 carboxy-terminal
tail removes numerous phosphorylation sites, the activa-
tion of the p70∆CT104 truncation mutant nevertheless
appears to require phosphorylation at (minimally) three
sites, catalyzed by two or three different protein kinases. 
We now describe the identification of one candidate acti-
vating-kinase for p70 S6 kinase; 3-phosphoinositide-
dependent protein kinase-1 (PDK1) is a recently
identified protein (serine/threonine) kinase that contains a
pleckstrin homology (PH) domain in its carboxy-terminal
noncatalytic segment [19]. PDK1 was previously shown to
activate in vitro protein kinase B (PKB, also known as c-
Akt) [19], a PI 3-kinase-regulated protein kinase, through a
phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3)-
stimulated-phosphorylation of PKB at Ser308, a residue in
the PKB activation loop that is homologous in location to
Thr252 in p70 [20]. We show here that PDK1 also phos-
phorylates p70 in vitro within the activation loop, selec-
tively at Thr252, resulting in activation of the p70 S6
kinase activity. PDK1-mediated phosphorylation and acti-
vation of p70 in vitro is independent of the presence of
PtdIns(3,4,5)P3 but is greatly influenced by the phospho-
rylation state of the p70 noncatalytic carboxy-terminal tail,
and by a negative charge at Thr412 of p70. These data
provide strong direct support for the importance of Thr252
in p70 activation, and reveal the highly synergistic interac-
tion between Thr252 and Thr412 in p70 activation. In
addition, they point to a multifunctional role for PDK1 in
signal transduction downstream of PI 3-kinase, and to a
model for the regulation of PDK1 in vivo by control of its
cellular localization and by substrate-directed mechanisms.
Results
PDK1 activates p70 S6 kinase upon cotransfection
The p70 mutant p70∆CT104 lacks the carboxy-terminal
104 amino acids but, like full-length p70, has a low activity
in serum-deprived cells which is rapidly activated by
insulin or mitogens (Figure 2), and is inhibited by sub-
micromolar concentrations of wortmannin and rapamycin
[14,18]. The similarity in the regulatory responses of
p70∆CT104 to those of the full-length p70, despite rem-
oval of a segment that contains numerous serine/threonine
residues whose phosphorylation is necessary for activation
of the full-length p70, has led us to use the truncation
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mutant to evaluate the ability of candidate kinases to
activate p70 kinase. Consistent with earlier findings
[15], co-expression of p70∆CT104 with a recombinant,
constitutively active PI 3-kinase (p110*) in CHO–IR cells
resulted in a robust activation of p70∆CT104, which was
not further augmented by pretreatment of the cells with
insulin. Similarly, co-expression with PDK1 induced com-
parable activation of p70∆CT104 to that seen with p110*.
PDK1 also activated full-length p70 on co-expression
(Figure 2b), although the extent of activation was more
modest than that observed with p70∆CT104, and could be
further augmented by pretreatment with insulin. Persis-
tent insulin-responsiveness of full-length p70 has also
been observed after co-expression with p110* [15] and has
been suggested to reflect a requirement for PI 3-kinase-
independent inputs that are eliminated by deletion of the
carboxy-terminal tail.
Burgering and Coffer [21] reported that co-expression of
full-length p70 with a constitutively active form of PKB
(gag–PKB) resulted in activation of p70 S6 kinase activ-
ity in vivo. We found that PKB, and especially gag–PKB,
gave substantial activation of p70∆CT104 (Figure 2c).
Alessi et al. [19] recently demonstrated that PDK1 can
activate PKB both in vivo, upon co-expression, as well as
in vitro, by direct phosphorylation of Thr308 in the PKB
activation loop; consequently, the ability of PDK1 to
activate p70 when co-expressed might be attributable to
PDK-induced activation of endogenous PKB. We there-
fore examined the ability of recombinant PKB and
PDK1 to phosphorylate and activate p70 S6 kinase
directly in vitro.
Expression of GST–p70∆CT104 and its phosphorylation by
PDK1
The cDNA encoding p70∆CT104 was fused in-frame with
the carboxyl terminus of glutathione S-transferase (GST)
in the vector pEBG [22]. GST–p70∆CT104 was expressed
in human embryonic kidney 293 cells and purified on
glutathione–Sepharose beads. The preparation showed a
major Coomassie blue-stained band of apparent molecular
mass 83kDa, corresponding to GST–p70∆CT104 fusion
protein (Figure 3). The purity, estimated by densitometric
analysis of the gels, was more than 80%, and 2 mg purified
GST–p70∆CT104 protein was obtained from forty dishes
(10 cm diameter) of 293 cells. The GST–p70∆CT104
fusion protein purified from unstimulated 293 cells had a
low activity (0.7U/mg), but, like the parent p70∆CT104, it
was activated 4–10-fold in response to stimulation with
insulin or mitogen. (See Materials and methods for the
definition of a unit.)
As reported previously [19], PDK1 expressed as a GST-
fusion protein (GST–PDK1) in 293 cells phosphorylated
GST–PKBα only in the presence of lipid vesicles con-
taining 10 µM PtdIns(3,4,5)P3 (Figure 4a). Interestingly,
under identical conditions, GST–PDK1 also phosphoryl-
ated GST–p70∆CT104, but this phosphorylation was not
dependent on the presence of lipid vesicles containing
72 Current Biology, Vol 8 No 2
Figure 2
PDK1 activates p70 S6 kinase during transient expression. CHO–IR
cells were transfected with plasmids encoding hemagglutin (HA)-
tagged HA–p70α1 full-length (b) or HA–p70∆CT104 (a,c), together
with pCMV5 vector (see Materials and methods) or pCMV5 plasmid
encoding PDK1, or p110*, PKB or gag–PKB, as indicated. After 48 h,
the cells were transferred to serum-free medium and 16 h later, insulin
(I, 10–7M) or carrier (B) was added. After 20 min, the cells were rinsed
in ice-cold PBS and extracted into ice-cold lysis buffer [14]; aliquots
matched for protein amounts were immunoprecipitated with the anti-
HA monoclonal antibody 12CA5. Washed immunoprecipitates were
assayed for 40 S kinase activity [14,15]; the assays were terminated
with SDS and subjected to SDS–PAGE and transferred to a
polyvinylidene difluoride membrane. After autoradiography, an anti-p70
peptide antibody was used for immunoblot of the HA–p70 proteins
[2]. Radioactive phosphate (32P) incorporated into S6 is indicated as
c.p.m. beneath the corresponding S6 band. Mock transfections were
cells treated with lipofectamine but no plasmid DNA.
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PtdIns(3,4,5)P3 (Figure 4a). No phosphorylation of
GST–p70∆CT104 was observed if PDK1 was omitted
(Figure 4a,b) or if a catalytically inactive mutant of
PDK1 was used (data not shown). Phosphorylation of
GST–p70∆CT104 by GST–PDK1 reached a plateau at
about 0.3 moles phosphate per mole protein, and addi-
tion of higher concentrations of GST–PDK1 into the
assay failed to increase phosphorylation beyond this
level. Maximal phosphorylation of GST–p70∆CT104 by
PDK1 increased the specific activity of
GST–p70∆CT104 three- to four-fold, to approximately
2 U/mg (Figure 4c). As with PDK1-catalyzed phosphory-
lation of GST–p70∆CT104, the activation of
GST–p70∆CT104 by GST–PDK1 was also unaltered by
the presence of PtdIns(3,4,5)P3, whereas, in parallel
incubations, the activation of GST–PKBα by
GST–PDK1 was completely dependent on the presence
of this 3-phosphoinositide in the assay (Figure 4b).
PDK1 purified from rabbit skeletal muscle also phospho-
rylated and activated GST–p70∆CT104 independently
of PtdIns(3,4,5)P3 and to a similar extent as did recombi-
nant GST–PDK1 (data not shown).
In contrast to the readily evident phosphorylation of
GST–p70∆CT104 catalyzed by GST–PDK1, active
GST–PKBα derived from 293 cells stimulated with
insulin-like growth factor-1 (IGF-1) [23] was not able to
phosphorylate GST–p70∆CT104 in vitro (Figure 4d). The
activity of the recombinant PKB was demonstrated by its
ability to phosphorylate histone H2B. (Figure 4d). Thus, it
appears that, whereas PDK1 directly phosphorylates and
activates both PKB and p70 in vitro, PKB lacks direct p70
kinase-kinase activity. In addition, p70 does not contain
the PKB consensus sequence for phosphorylation, namely
Arg–X–Arg–X–X–Ser/Thr–Hyd, where X is any amino
acid and Hyd is a large hydrophobic residue [24].
PDK1 phosphorylates Thr252 of p70 S6 kinase
The GST–p70∆CT104 fusion protein was phosphorylated
to 0.25 mole phosphate per mole protein by GST–PDK1,
digested with trypsin, and the resulting peptides were
chromatographed on a C18 column at pH1.9. Only one
major 32P-labelled tryptic peptide (termed P1), eluting at
31% acetonitrile was observed (Figure 5a). The peptide
digests contained phosphothreonine only (data not
shown); the sequence of the 32P-labelled tryptic peptide
commenced at residue 242 of p70 S6 kinase and a single
burst of radioactivity was released after the eleventh cycle
of Edman degradation (Figure 5c). This finding estab-
lishes that PDK1 phosphorylated GST–p70∆CT104 at
Thr252, which lies nine residues upstream of the sub-
domain VIII of the catalytic domain [9]. This conclusion is
further supported by the inability of GST–PDK1 to cat-
alyze significant phosphorylation of the inactive mutant,
p70∆CT104 (Thr252→Ala) (Figures 5b,6b). Predictably,
the amino-acid residues surrounding Thr252 of p70 S6
kinase are highly homologous to those found surrounding
Thr308 of PKBα [19]. PDK1 purified from rabbit skeletal
muscle also phosphorylated Thr252 of p70 S6 kinase (data
not shown).
The role of the p70 carboxy-terminal tail
To characterize the phosphorylation of p70 S6 kinase by
PDK1 further, we compared the phosphorylation and
activation of a variety of p70 S6 kinase mutants following
incubation with both high (9 nM) and low (0.9 nM) con-
centrations of GST–PDK1. All of the GST–p70 S6
kinase mutants were expressed in 293 cells, purified by
affinity chromatography on glutathione–Sepharose and
found to be more than 80% homogenous as judged by
SDS–polyacrylamide gel electrophoresis (Figure 3). A
catalytically inactive ATP-site mutant (Lys123→Met) of
GST–p70∆CT104 was phosphorylated by GST–PDK1 at
Research Paper  PDK1 activates p70 S6 kinase Alessi et al.    73
Figure 3
SDS–polyacrylamide gel of purified GST–p70
S6 kinase fusion proteins. Human embryonic
kidney 293 cells were transiently transfected
with the pEBG DNA constructs (see Materials
and methods) expressing the wild-type and
mutant forms of GST–p70 S6 kinase. After
24 h, the cells were deprived of serum for
16 h, washed, extracted into Buffer A (see
Materials and methods), and the GST–p70 S6
kinase proteins were purified by affinity
chromatography on glutathione–Sepharose.
An aliquot (2µg) of the glutathione–Sepharose
eluate was subjected to electrophoresis on a
10% SDS–polyacrylamide gel, which was
stained with Coomassie blue. Lane 1,
p70∆CT104; lane 2, full-length p70; lane 3,
p70∆CT104 (Thr252→Ala); lane 4, full-length
p70 (5 Ala); lane 5, p70∆CT104 (Lys123→
Met); lane 6, p70∆CT104 (Thr412→Ala);
lane 7, p70∆CT104 (Thr412→Glu); lane 8,
p70∆CT104 (Ser394→Ala); lane 9,
p70∆CT104 (Ser394→Asp); lane 10,
p70∆CT104 (Ser394→Asp/Thr412→Glu);
lane 11, p70∆2–46/∆CT104; lane 12,
p70∆2–46. The positions of the molecular
mass markers, glycogen phosphorylase
(97 kDa) and bovine serum albumin (66 kDa),
are indicated.
1 2 3 4 5 6 7 8 9 11kDa
97
66
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about one half the rate of the active GST–p70∆CT104
mutant, but, as expected, the negligible activity of the
ATP-site mutant was not thereby altered (Figure 6a,b).
To examine the influence of the p70 carboxy-terminal tail
on PDK1-catalyzed p70 phosphorylation and activation,
we made a full-length p70 mutant in which five residues
(Ser434, Ser441, Thr444, Ser447, Ser452), which corre-
spond to phosphorylation sites in the autoinhibitory
psuedosubstrate domain of the carboxy-terminal tail, were
changed to alanine (GST–p70 (5Ala)). The GST–p70 full-
length and the GST–p70∆CT104 fusion proteins had very
similar basal activities after purification from 293 cells,
whereas the GST–p70 (5Ala) mutant had a basal specific
activity that was almost 90% lower (Figure 6a). When the
three GST–p70 fusion proteins were adjusted to the same
concentration and phosphorylated by GST–PDK1, each
was found to have some increase in S6 kinase activity
(Figure 6b). The GST–p70 (5Ala) mutant was phosphory-
lated by 9nM GST–PDK1 to half the extent of the
GST–p70 full-length protein and one fifth the extent of
GST–p70∆CT104. The absolute increase in S6 kinase
activity of GST–p70 (5Ala) was one half to one third that
of the GST–p70 full-length protein, and less than 10%
that of GST–p70∆CT104. The GST–p70∆CT104 protein
was phosphorylated by 0.9 nM GST–PDK1 at a five-fold
higher initial rate, and by 9nM GST–PDK1 to a two- to
three-fold greater extent than was the GST–p70 full-
length protein (Figure 6b). Moreover, the absolute
increase in S6 kinase activity of GST–p70∆CT104 was
nearly five-fold greater when compared to the GST–p70
full-length protein (Figure 6a). These data show that the
carboxy-terminal tail controls both the access of PDK1 to
Thr252 and the extent of p70 activation achieved by any
level of PDK1-catalyzed Thr252 phosphorylation. The
second point is demonstrated by the observation that 9nM
GST–PDK1 catalyzed Thr252 phosphorylation of the full-
length GST–p70 (5Ala) and full-length, unmodified
GST–p70 to 0.07 and 0.14 moles phosphate per mole
protein, respectively (Figure 6b), resulting in increments
in specific activity of 0.12 and 0.33 U/mg, respectively
(Figure 6a). By comparison, 0.9 nM GST–PDK1 catalyzed
Thr252 phosphorylation of the GST–p70∆CT104 to 0.09
moles phosphate per mole protein (Figure 6b), with a con-
comitant increase in specific activity of 0.82 U/mg
(Figure 6a).
The ability of the carboxy-terminal tail to control the
access of PDK1 to Thr252 was further demonstrated by
the behavior of the p70 amino-terminal deletion mutants,
p70∆2–46 and p70∆2–46/∆CT104 (Figure 6c,d). Deletion
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Figure 4
Phosphorylation and activation of GST–PKBα and GST–p70∆CT104
by PDK1. GST–PKBα or GST–p70∆CT104 was incubated for 30 min
at 30°C with Mg–[γ-32P]ATP in the presence or absence of
GST–PDK1 (9 nM) and phospholipid vesicles containing 100 µM
phosphatidylcholine, 100 µM phosphatidylserine, and 10 µM
D-enantiomer of sn-1-stearoyl, 2-arachidonyl PtdIns(3,4,5)P3 . (a) The
reactions were terminated by making the solutions 1% in SDS, the
samples were subjected to SDS–PAGE, and the phosphorylation was
assessed by autoradiography of the gel. The Coomassie blue-stained
band corresponding to GST–PKBα or GST–p70∆CT104 is indicated
with an arrow. (b) The increase in specific activity of GST–PKBα
(U/mg) was determined, relative to a control incubation in which
GST–PDK1 was omitted. The basal activity of GST–PKBα was
2.5 U/mg. (See Materials and methods for the definition of a unit.)
(c) The specific activity of GST–p70∆CT104 was determined. (b,c)
The results are presented as mean ± SEM for six determinations in
two independent experiments. (d) GST–PKBα, derived from IGF-1
stimulated 293 cells [23] (10 U/ml final activity) was incubated with
Mg–[γ-32P]ATP and GST–p70∆CT104 (2 µg, lanes 2 and 3) or
histone H2B (2 µg, lanes 4 and 5), for 30 min at 30°C. The reactions
were terminated by addition of SDS to 1%. After SDS–PAGE, the
gel was stained with Coomassie blue and subjected to
autoradiography. The bands corresponding to GSTp70∆CT104
and histone H2B are indicated.
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of amino acids 2–46 resulted in a marked decrease in p70
specific activity, which was reversed if the p70 carboxy-
terminal tail was also deleted [14,18]. This pattern, previ-
ously observed with HA-tagged p70 proteins, is also
evident with GST–p70 fusion proteins (Figure 6c). As
shown in Figure 6d, PDK1 was not able to phosphorylate
Thr252 in the GST–p70∆2–46 truncation mutant; con-
comitant deletion of the carboxy-terminal tail (GST–
p70∆2–46/∆CT104) not only increased the specific activ-
ity of the enzyme when isolated from 293 cells, but also
restored the ability of PDK1 to phosphorylate the p70
protein in vitro and thereby activate the S6 kinase.
The role of Thr412
A Thr412→Ala mutation of GST–p70∆CT104 reduced
the basal level of activity more than 10-fold (Figure 6a).
GST–p70∆CT104 (Thr412→Ala) was phosphorylated by
GST–PDK1 at a two- to three-fold higher rate than was
GST–p70∆CT104, and to a maximal stoichiometry of
0.8 moles phosphate per mole protein, resulting in a five-
fold activation. Nevertheless, the specific activity of
Thr252-phosphorylated-GST–p70∆CT104 (Thr412→Ala)
remained at 10% that of the less extensively phosphory-
lated GST–p70∆CT104 (about 0.3 moles phosphate per
mole protein; Figure 6a). A GST–p70∆CT104 fusion
protein in which Thr412 was mutated to glutamate had a
basal level of activity that was about 20-fold higher than
that of the unmodified GST–p70∆CT104 protein (Figure
6a). Phosphorylation of GST–p70∆CT104 (Thr412→Glu)
with 9 nM GST–PDK1 resulted in a further three-fold
activation of this enzyme to a specific activity of nearly
50 U/mg, with a concomitant increase in phosphorylation
to a stoichiometry of 0.9 moles phosphate per mole
protein (Figure 6a,b). Thus, PDK1 phosphorylates
Thr252 regardless of whether residue 412 is a threonine,
alanine or glutamate, (although much more readily in the
case of the latter two variants) and activates each variant to
a similar relative extent (about three- to four-fold). The
absolute extent of activation, however, is dependent on
the initial specific activity. This feature led us to investi-
gate whether the very high initial specific activity of
GST–p70∆CT104 (Thr412→Glu) is attributable directly
to the presence of a negative charge at residue 412, or
whether mutations at Thr412 alter the phosphorylation of
other potentially activating residues in vivo. 
In fact, treatment in vitro of GST–p70∆CT104 and
GST–p70∆CT104 (Thr412→Glu), isolated from serum-
deprived cells, with a high concentration of protein phos-
phatase 2A1 (PP2A1) resulted in a profound decrease in S6
kinase activity. The decrease was 80% (to 0.15U/mg) for
GST–p70∆CT104 (Figure 7a) and 90–95% (to approxi-
mately 1.0U/mg) for GST–p70∆CT104 (Thr412→Glu)
(Figure 7c). Phosphorylation of PP2A1-treated GST–
p70∆CT104 with GST–PDK1 and Mg–ATP resulted in a
marked activation of GST–p70∆CT104, about 15-fold, to
a specific activity of 2.2 U/mg (Figure 7a). The time course
of GST–PDK1-catalyzed phosphorylation of PP2A1-
treated and untreated GST–p70∆CT104 was identical,
with both reaching plateau phosphorylation at about
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Figure 5
PDK1 phosphorylates Thr252 of p70 S6 kinase. (a) GST–p70∆CT104
or (b) GST-p70∆CT104 (Thr252→Ala) was maximally phosphorylated
by incubation with GST–PDK1 (9nM) and Mg–[γ-32P]ATP (100µM) for
1h at 30°C, alkylated with 4-vinylpyridine and digested with trypsin. The
digest was applied to Vydac 218TP54C18 column (Separations Group)
equilibrated in 0.1% (v/v) trifluoroacetic acid in water. The column was
developed with a linear acetonitrile gradient (diagonal line) at a flow rate
of 0.8ml/min and fractions of 0.4ml were collected. (a) 65% of the
radioactivity applied to the column was recovered in the major 32P-
containing peptide eluting at 31% acetonitrile, designated P1; the
remainder of the radioactivity eluted as numerous minor peaks. (c) A
portion of the P1 sample (10pmol) was analyzed on an Applied
Biosystems 476A sequencer to determine the amino-acid sequence,
and the phenylthiohydantoin (Pth) amino acids identified after each
cycle of Edman degradation on the sequencer (shown under the chart,
using the single-letter code for amino acids). To identify the site(s)
phosphorylated on P1, another aliquot (900c.p.m.) was subjected to
one cycle of Edman degradation on the sequencer to remove the amino-
terminal glutamate [28] and the resulting peptide was then coupled
covalently to a Sequelon arylamine membrane and analyzed on the
sequencer using the modified program described in [28]. Radioactivity
(32P) released was measured after each cycle of Edman degradation.
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0.25 moles phosphate per mole protein (Figure 7b). Phos-
phorylation of the PP2A1-treated GST–p70∆CT104
(Thr412→Glu) by PDK1 and Mg–ATP resulted in a
30–40-fold activation and restored the activity of PP2A1-
treated GST–p70∆CT104 (Thr412→Glu) to 80–90% of
that achieved by PDK1 phosphorylation of the
GST–p70∆CT104 (Thr412→Glu) protein which had not
been pretreated with PP2A1 (Figure 7c). Estimation of the
extent of phosphorylation of GST–p70∆CT104
(Thr412→Glu) by PDK1 is somewhat confounded by the
occurrence of autophosphorylation, which is reduced sub-
stantially by pretreatment with PP2A1. Nevertheless, the
autophosphorylation of GST–p70∆CT104 does not seem
to lead to activation (Figure 7c,d). Correcting approxi-
mately for this autophosphorylation, it appears that PP2A1
pretreatment of GST–p70∆CT104 (Thr412→Glu) does
not significantly alter the extent of subsequent phospho-
rylation by GST–PDK1. 
The role of Ser394
Ser394 is a site of mitogen-stimulated phosphorylation in
vivo, and mutation of this residue to alanine diminishes
p70 activity by about 90% [17]. Although PDK1-catalyzed
phosphorylation of p70∆CT104 (Ser394→Ala) was
reduced somewhat when compared to that of p70∆CT104,
a more significant factor is that phosphorylation at Thr252
in the p70∆CT104 (Ser394→Ala) mutant was much less
effective in increasing S6 kinase activity, which remained
15–20% of that achieved with p70∆CT104 (Figure 6c,d).
Conversion of Ser394 to aspartate did not result in
increased PDK1-catalyzed Thr252 phosphorylation, but
restored S6 kinase activity to levels at least 50% of the
activity of p70∆CT104 (Thr412→Glu) when phosphory-
lated at Thr252 to a comparable extent. The impact of the
Ser394→Ala mutation on S6 kinase activity could be an
indirect one, inasmuch as the Ser394→Ala mutation has
been observed to substantially diminish Thr412 phospho-
rylation in vivo [17]. Nevertheless, it appears that phos-
phorylation of Ser394 is required for substantial S6 kinase
activity, independent of the phosphorylation state of
Thr252.
Discussion
The results presented here demonstrate that PDK1, the
kinase that activates PKB in vitro in a PtdIns(3,4,5)P3-
dependent manner by phosphorylating Ser308 in the PKB
activation loop [19], also activates p70 S6 kinase through
phosphorylation at a homologous site, Thr252. This
finding establishes that the insulin-stimulated and
mitogen-stimulated, PI 3-kinase-directed phosphorylation
76 Current Biology, Vol 8 No 2
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Phosphorylation and activation of p70 S6 kinase mutants by PDK1. The
GST–p70 S6 kinase mutants (1.5µg) indicated were incubated for 30
min at 30°C with Mg–[γ-32P]ATP (100µM) in the absence or presence
of GST–PDK1 (9 nM or 0.9 nM). (a,c) The specific activity (U/mg) of
p70 S6 kinase after incubation was determined. (b,d) The reactions
were made 1% in SDS, subjected to SDS–PAGE, and the extent of
phosphorylation was assessed by measuring the 32P radioactivity
associated with the Coomassie blue-stained band corresponding to the
respective GST–p70 fusion protein. The results are presented as mean
± SEM for six to nine determinations from three separate experiments.
of p70 at Thr252 that occurs in vivo is a critical component
of the activation of p70 in vivo. Moreover, the ability of
PDK1 to phosphorylate Thr252 selectively in vitro has
enabled an informative analysis of the contributions of
other p70 domains and phosphorylation sites to the activa-
tion process.
The p70 carboxy-terminal tail encodes a psuedosubstrate
autoinhibitory domain, which in its unphosphorylated
state was predicted to be important to maintaining the low
basal activity of the enzyme [9]. The data presented here
demonstrate that the carboxy-terminal tail may suppress
p70 activity by at least two mechanisms. First, the carboxy-
terminal tail, particularly when not phosphorylated (as in
the 5 Ala substituted form), restricts the ability of PDK1 to
phosphorylate Thr252 in vitro, and probably serves a
similar function in vivo. This ‘gating’ function is controlled
both by the phosphorylation of the multiple serine–proline
and threonine–proline residues clustered in the autoin-
hibitory psuedosubstrate domain and by a contribution
from the p70 amino-terminal noncatalytic segment, amino
acids 2–46 (or more specifically, amino acids 29–46 [14]).
The p70∆2–46 mutant, although exhibiting unimpaired
phosphorylation of the carboxy-terminal tail in vivo
[14,18], has a very low activity in vivo and is unable to
undergo PDK1-catalyzed phosphorylation in vitro; the
p70∆2–46 mutant is also severely deficient in the phos-
phorylation of Thr412 in vivo ([18], Q.-P.W., M.T.K., and
J.A., unpublished observations). Whether the failure of
PDK1 to catalyze Thr252 phosphorylation in vitro is due to
a lack of displacement of the carboxy-terminal tail, or the
absence of Thr412 phosphorylation, cannot therefore be
unequivocally determined. Nevertheless, all these defects
are reversed by further deletion of the carboxy-terminal
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Figure 7
Effect of dephosphorylation on the activity of
GST–p70∆CT104 and GST–p70∆CT104
(Thr412→Glu) and their subsequent
phosphorylation and activation by PDK1. 
(a,b) GST–p70∆CT104 and (c,d)
GST–p70∆CT104 (Thr412→Glu), each at a
concentration of 0.5 mg/ml, were incubated
with either PP2A1 (100 mU/ml, squares) or the
equivalent amount of PP2A1 that had been
inactivated by incubation in 10 µM
microcystin-LR (circles). After incubation for
30 min at 30°C, microcystin-LR was added to
all incubations not already containing this toxin
to a concentration of 10 µM, together with
Mg(Ac)2 (10 mM) and [γ-32P]ATP (100 µM).
GST–PDK1 (9 nM final concentration, filled
symbols) or an equivalent volume of buffer
(open symbols) was then added, and at the
indicated time points, the specific activity (a,c)
and the extent of phosphorylation (b,d) of
GST–p70∆CT104 (a,b) or GST–p70∆CT104
(Thr412→Glu) (c,d) was determined as
described in the Materials and methods. The
results are presented as the mean of six
determinations from three separate
experiments (the SEM for each data point 
was < 15%).
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tail. Whether the input provided by the amino acid 2–46
segment is subject to regulation is not known, although it
should be mentioned that deletion of this segment also
abrogates p70 inhibition by rapamycin [14]. 
A second function of the carboxy-terminal tail, indepen-
dent of its ability to gate access of p70 kinase-kinases to
sites whose phosphorylation is critical for p70 kinase acti-
vation, is the ability of the nonphosphorylated tail to sup-
press the extent of increase in p70 catalytic activity
produced by any level of Thr252 phosphorylation. This
may reflect the ability of the nonphosphorylated psuedo-
substrate autoinhibitory domain to bind to, and to occlude,
the substrate-binding site; alternatively, or in addition, the
nonphosphorylated tail may interfere with the synergistic
interaction between the phosphorylated Thr252 and
Thr412 residues. 
The importance of the residue 412 of p70 to activation of
the p70 kinase is clearly shown by these studies, and the
basis for its function is uncovered, at least in part. One
important function of Thr412 is indicated by the increased
extent in vitro of PDK1-catalyzed Thr252 phosphorylation
in the p70∆CT104 mutant that results when Thr412 is
replaced by either an alanine or a glutamate. This suggests
that Thr412, presumably in its unphosphorylated state,
restricts the phosphorylation of p70∆CT104 at Thr252 in
vitro. In vivo, however, replacement of Thr412 by alanine
or glutamate in full-length p70 abolishes, or greatly dimin-
ishes, respectively, Thr252 phosphorylation. Thus, Thr412
phosphorylation in full-length p70 may be required to dis-
lodge the carboxy-terminal tail and make Thr252 available;
deletion of the carboxy-terminal tail eliminates this func-
tion and uncovers the restricting effect of Thr412.
Apart from the role of Thr412 in regulating the phospho-
rylation of Thr252, the data presented here establish the
potent functional synergy between the phosphorylation of
Thr252 and that of Thr412 in the activation of p70 S6
kinase. Earlier studies did not resolve whether the low
activity of the Thr412→Ala mutant is attributable to the
absence of a negative charge at residue 412, or to the
resultant failure of Thr252 to undergo phosphorylation in
vivo. PDK1 is able to phosphorylate Thr252 in the GST–
p70∆CT104 (Thr412→Ala) mutant in vitro, to an extent
far exceeding that achieved for GST–p70∆CT104. Never-
theless, although the normally very low basal activity of
GST–p70∆CT104 (Thr412→Ala) is thereby increased
five-fold, its maximal activity remains no more than 10%
that of the far less extensively Thr252-phosphorylated
GST–p70∆CT104 parent. Thus, nearly stoichiometric
phosphorylation of Thr252 alone is insufficient to give
substantial p70 activity. 
Reciprocally, the very high basal activity of the
GST–p70∆CT104 (Thr412→Glu) mutant can be reduced
to very low levels by treatment with PP2A1 (Figure 7c),
demonstrating that a negative charge at every residue 412
by itself is insufficient to give more than a small percentage
of the maximal p70 activity. Nevertheless, phosphorylation
of the PP2A1-treated GST–p70∆CT104 (Thr412→Glu) by
PDK1 selectively at Thr252, to a stoichiometry of about 0.5
moles phosphate per mole protein (Figure 7d), results in a
30–40-fold activation (Figure 7c), revealing the remarkably
synergistic functional interaction between phosphorylated
Thr252 and Glu412 (and, presumably, phosphorylated
Thr412 in the wild-type enzyme). Thus, although we do
not know the extent of Thr252 phosphorylation in
GST–p70∆CT104 (Thr412→Glu) as compared to GST-
p70∆CT104 (or the extent of Thr412 phosphorylation in
the latter), it appears likely that the presence of a glutamate
at each residue 412 will ensure that every phosphorylated
Thr252 residue participates in an activating conformation. 
The p70 Thr412 residue is situated in a hydrophobic
segment within a 65 amino-acid domain that is positioned
immediately carboxy-terminal to the canonical catalytic
domain [9]. This carboxy-terminal extension of the cat-
alytic domain is homologous (about 40% sequence iden-
tity) to similarly located domains found in the PKCs,
PKBα and PKBβ, and the Rsk amino-terminal kinase
domain [9]. Moreover, each of these kinases contains,
within this domain, sites of phosphorylation that are
homologous to p70 Thr412 in both location and sequence
context and are critical to activation of the respective
kinase—for example, the PKB Ser473 residue, which
together with PKB Thr308 (homologous to p70 Thr252),
is concurrently phosphorylated in vivo in an insulin-stimu-
lated, wortmannin-inhibited fashion [20]. The synergistic
activation of PKB by site-specific phosphorylation in the
activation loop and in the carboxy-terminal extension of
the catalytic domain is closely analogous to that of
GST–p70∆CT104. Although PDK1 can phosphorylate
both PKB Ser308 and p70 Thr252 effectively in vitro, the
phosphoinositide-regulated kinases that act on p70
Thr412 and PKB Ser473 remain to be identified.
The role of Ser394 phosphorylation in the PDK1-medi-
ated activation of GST–p70∆CT104 is different from that
of Thr412; although phosphorylation of Ser394 appears to
be crucial for maintaining the S6 kinase activity at levels
greater than 20% those of the wild-type enzyme, no evi-
dence of a functional interaction between Ser394 and
either Thr252 or Thr412 is evident. Thus, the phosphory-
lation/dephosphorylation of Ser394 provides a third level
of regulation, independent of the interacting inputs
directed at Thr252 and Thr412. Ser394 is followed imme-
diately by a proline residue, as in the multiple sites resid-
ing in the autoinhibitory psuedosubstrate domain in the
carboxyl terminus. It is not known, however, whether
Ser394 is phosphorylated by the same proline-directed
kinases that act on the p70 carboxy-terminal tail [13].
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Ser394 is located in the equivalent position to the Thr450
residue of PKB, which is also followed immediately by a
proline and is phosphorylated in vivo. PKB Thr450 phos-
phorylation is, however, not stimulated by insulin or
IGF-1 [20].
The ability of PDK1 to phosphorylate p70 Thr252 and to
activate the p70 S6 kinase activity in vitro raises the ques-
tion of whether PDK1 is the enzyme responsible for the PI
3-kinase-dependent phosphorylation of p70 Thr252 in
response to stimulation by insulin and mitogen, as has
been proposed for PKB Ser308. Notably, although 3-phos-
phoinositides greatly increase the rate of PDK1 phosphory-
lation of PKB in vitro, PDK1 phosphorylates GST–
p70∆CT104 at a comparably high rate in the absence of
PtdIns(3,4,5)P3, and addition of these lipids to the assay
does not alter the rate of PDK1-catalyzed p70 phosphoryla-
tion or activation (Figure 4). The relatively high,
PtdIns(3,4,5)P3-independent (GST–p70∆CT104) kinase
activity exhibited in vitro by recombinant GST–PDK1
purified from serum-deprived cells raises the question of
whether PDK1 is a plausible candidate p70 kinase in vivo;
the related question is whether, and by what means, PDK1
activity is regulated in vivo. Treatment of cells with insulin
or IGF-1, which results in a 20–40-fold increase in the
activity of PKB [20], does not alter the ability of endoge-
nous or recombinant PDK1 to phosphorylate PKB in vitro,
either in the presence or the absence of PtdIns(3,4,5)P3
[19]. Thus, although PtdIns(3,4,5)P3 does bind to PDK-1
with high affinity (R. Currie, C.P. Downes and D.R.A.,
unpublished observations), the lipid does not appear to
stimulate the catalytic activity of purified or recombinant
PDK1. Previous work has established that a dominant part
of the ability of PtdIns(3,4,5)P3 to stimulate PDK1-cat-
alyzed PKB phosphorylation is attributable to the binding
of the lipid to the PKB substrate, thereby making PKB
Ser308 accessible to PDK1 [19]. Thus, the marked
PtdIns(3,4,5)P3 dependence of PDK1-catalyzed PKB acti-
vation in vitro probably reflects the binding of both PDK1
and PKB to the lipid vesicles, thereby promoting their con-
tiguity, together with a PtdIns(3,4,5)P3-induced alteration
in PKB conformation, which promotes the availability of
PKB Ser308 to phosphorylation by PDK1. 
A likely situation in the cell is that PDK1 is constitutively
active but unable to access p70 Thr252, because this
residue is sequestered within the p70 structure in the con-
formation specified by the dephosphorylated Thr412 and
by the unphosphorylated p70 carboxy-terminal tail
(Figure 8). Moreover, in view of the marked site–site
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Figure 8
A model for the activation of the p70 S6
kinase in response to insulin and mitogens.
The process is divided into four steps. Step
1 involves the action of an array of proline-
directed kinases, including the Ras-
dependent activation of MAP kinases, SAP
kinases, p38s, and Cdc2 [12], which
phosphorylate the p70 carboxy-terminal tail
(Ser434, Ser441, Thr444, Ser447, and
Ser452), and perhaps Ser394 in the
carboxy-terminal extension of the catalytic
domain. PI 3-kinase, when activated strongly,
may activate Ras sufficiently to engage this
step; strong activation of Ras may also
activate the PI 3-kinase. The broken arrow
indicates the possibility that PI 3-kinase may
activate proline-directed kinases
independently of Ras, for example, through
the Rho family of GTPases. Step 2 involves
the release of the phosphorylated carboxy-
terminal tail of p70 from the catalytic domain,
providing access to Thr412 and Thr252. The
existence of this step is inferred from the
ability of the ∆2–46 deletion to interrupt p70
activation at this point; whether this step is
regulated is not known. Step 3 involves the
phosphorylation of Thr412 by a
PtdIns(3,4,5)P3-dependent kinase. This
alone produces only a slight activation of S6
kinase activity, but facilitates access to
Thr252 and sets up the conformation
necessary for a concerted activation. Step 4
involves PDK1-catalyzed phosphorylation of
Thr252, resulting in full activation of the S6
kinase, due to the strong positive
cooperativity between the phosphorylated
Thr412 and Thr252 residues. Inactivation
may be achieved by dephosphorylation at
either site. Steps 3 and 4 probably occur in
a concerted fashion, because all of the
components (Thr412 kinase, PDK1 and p70)
are probably assembled close together
through the mediation of PtdIns(3,4,5)P3.
PKC isoforms may also contribute in part to
the activation of p70 by mitogen but the
steps that are facilitated and the elements
employed are not known. Similarly, the role
of the target of rapamycin in mammalian
cells, mTOR, in p70 regulation is not
addressed by the data presented.
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interaction required for p70 activation, any phosphorylation
of p70 Thr252 that occurs in the absence of concomitant
(3-phosphoinositide stimulated) p70 Thr412 phosphoryla-
tion is unlikely to generate significant p70 activation in
vivo. Thus, our model for the activation of the p70 S6
kinase by insulin and mitogens (Figure 8) proposes that
the initial step is Ras-directed phosphorylation of the p70
carboxy-terminal tail, catalyzed by proline-directed
mitogen-activated kinases [13], distinct from PDK1 and
from the Thr412 kinase; this enhances the accessibility of
Thr252 (and perhaps Thr412). Activation of PI 3-kinase
and the synthesis of 3-phosphoinositides recruits PDK1 to
the membrane and probably the 3-phosphoinositide-
dependent Thr412 kinase as well. Phosphorylation at
Thr412, by the as yet unidentified PtdIns(3,4,5)P3-regu-
lated protein kinase(s), further facilitates PDK1-catalyzed
Thr252 phosphorylation. The concurrent phosphorylation
of Thr412 and Thr252 results in the strong positively coop-
erative site–site interaction that is the dominant factor in
p70 activation. Thus, phosphorylation and disengagement
of the p70 carboxy-terminal tail, together with phosphory-
lation of p70 Thr412, enables access of PDK1 to the p70
activation loop, much as binding of phosphatidylinositol
3,4-bisphosphate (PtdIns(3,4)P2) to the PKB PH domain
facilitates access of PDK1 to the PKB activation loop. We
suggest that regulation of PDK1 by the PI 3-kinase is indi-
rect—it is not achieved by an increase in PDK1-intrinsic
specific activity, but by an enhanced accessibility of its
target sites and by the regulation of its intracellular local-
ization through the interaction with phosphoinositides.
This model implies that a mechanism must exist to recruit
p70 to the vicinity of these PtdIns(3,4,5)P3-associated
kinases, perhaps through the interaction of p70 with small
GTPases of the Rho subfamily [25].
Materials and methods
Materials and buffer solutions
The D enantiomer sn-1-stearoyl-2-arachidonyl PtdIns(3,4,5)P3 was a
gift from P. Gaffney and GST–PKBα was prepared as described [23].
The peptides used to assay PKBα, (RPRAATF) [24] and p70 S6
kinase (KKRNRTLTV) [26] and TTYADFIASGRTGRRNAIHD (the spe-
cific peptide inhibitor of cyclic AMP-dependent protein kinase, termed
PKI) were synthesized by F Barry Caudwell on an Applied Biosystems
431A peptide synthesizer, and their concentrations were determined
by quantitative amino-acid analysis. Glutathione–Sepharose was pur-
chased from Pharmacia, alkylated trypsin and chymotrypsin from
Promega. The sources of all other materials were described in [19].
Buffer A contained 50 mM Tris/HCl pH 7.5, 1 mM EDTA 1 mM EGTA,
1% (by volume) Triton X-100, 1 mM sodium orthovanadate, 10 mM
sodium β-glycerophosphate, 50 mM NaF, 5 mM sodium pyrophos-
phate, 1 µM microcystin-LR, 0.27 M sucrose, 1 mM benzamidine,
0.2 mM phenylmethylsulphonyl fluoride (PMSF), 10 µg/ml leupeptin,
0.1% (by volume) 2-mercaptoethanol. Buffer B contained 50 mM
Tris/HCl pH 7.5, 0.1 mM EGTA, and 0.1% (by volume) 2-mercap-
toethanol.
Plasmid constructs
The HA tagged full-length p70α1, p70α1CT104 [14], the Myc-tagged
PDK1 in the pCMV5 vector or in the pEBG2T vector [19], constitu-
tively active PI 3-kinase, p110* [15], PKB and gag–PKB [21] were as
previously described. The vector pEBG [22] was modified to accom-
modate previously constructed p70 variants, by insertion of a new
polylinker that encodes in the following order, NotI, SpeI, KpnI, ClaI,
SmaI, SalI, and BamHI restriction sites. Subcloning from pMT2 into the
modified pEBG involved excision of the pMT2 inserts using NotI and
BamHI; the p70 variants thus transferred were full-length p70α1,
p70α1CT104, p70α1CT104 (Lys123→Met), p70α1CT104
(Thr252→Ala), p70∆2–46 and p70∆2–46/∆CT104 [14]. Additional
p70α1 mutants including Ser394→Ala, Ser394→Asp, Thr412→Ala,
Thr412→Glu, 5 Ala (Ser434→Ala, Ser441→Ala, Thr444→Ala,
Ser447→Ala, Ser452→Ala), were constructed by digestion of the
pMT2 full-length p70α1 or p70α1∆CT104 plasmids with XhoI and
BspMI and ligation of a XhoI/BspMI double-digested polymerase chain
reaction (PCR) fragment prepared by a two-step PCR [14]. The
Ala394/Glu412 and Asp394/Glu412 double mutants were generated
from plasmids carrying the Ala394 and Asp394 mutations, respec-
tively, using mutagenic oligonucleotides encoding Ala412 and Glu412.
Diagnostic restriction sites were engineered into the mutants as
follows: Ala394, SalI; Asp394, SalI; Ala412, BsiWI; Glu412, BstB1;
5 Ala, ApoI.
Expression of GST–p70 S6 kinase constructs
Twenty 10 cm diameter dishes of human embryonic kidney 293 cells
were each transfected with 20 µg pEBG plasmid DNA encoding the
p70 S6 kinase mutants described above, using a modified calcium
phosphate method [19]; 24 h after transfection, the cells were serum
starved for 16 h and the cells in each dish were lysed in 1 ml ice-cold
Buffer A. The 20 lysates were pooled, centrifuged at 4°C for 10 min at
13,000 g and the supernatant incubated at 4°C for 60 min on a rotat-
ing platform with 1 ml of glutathione–Sepharose previously equilibrated
in Buffer A. The suspension was centrifuged for 1 min at 3000 g, the
beads washed three times with 10 ml Buffer A containing 0.5 M NaCl,
and then a further 10 times with 10 ml Buffer B [19]. GST–p70 S6
kinase fusion proteins were eluted from the beads at ambient tempera-
ture with three 1 ml portions of Buffer B containing 20 mM glutathione
pH 8.0. The combined eluates were divided into aliquots, snap frozen in
liquid nitrogen, and stored at –80°C. Between 0.5 and 2.0 mg of each
GST-fusion protein was recovered at a purity of 80% or more, as
judged by SDS–polyacrylamide gel electrophoresis (Figure 2).
Transient transfection experiments
CHO–IR cells grown in Ham’s F12 medium with 10% fetal bovine
serum were transfected with HA–p70 or HA–p70∆CT104 [14] alone
or with p110* [15], Myc–PDK1 in the pCMV5 vector [19], PKB or
gag–PKB [21]. Two days later, the cells were deprived of serum for
16 h, and exposed to insulin (10–7M) or carrier for 20min prior to
harvest. Cell extracts were prepared at 4°C, cleared by centrifugation,
and aliquots matched for protein were subjected to immunoprecipita-
tion with the anti-HA monoclonal antibody 12CA5. The immunoprecipi-
tates were assayed for 40S kinase activity as before [14,27]. Reactions
were terminated with SDS, subjected to SDS–polyacrylamide gel elec-
trophoresis, transfered to PVDF membranes, subjected to autoradiogra-
phy and immunoblot analysis using anti-p70 antiserum [2].
Activation of p70 S6 kinase proteins by PDK1
The assay was carried out in two stages. In the first stage, GST–p70
S6 kinase was incubated with either 9 nM or 0.9 nM PDK1 in the pres-
ence of Mg–ATP. In the second stage, Mg–[γ32–P]ATP, and a specific
p70 peptide substrate, KKRNRTLTV were added. In stage 1, an 18 µl
reaction mixture containing 50 mM Tris-HCl pH 7.4, 0.1 mM EGTA,
0.1% (by volume) 2-mercaptoethanol, 0.1 mM EGTA, 2.5 µM PKI, 1 µM
microcystin-LR, 10 mM Mg(Ac)2, 100 µM unlabelled ATP and 0.6 µM
GST–p70 S6 kinase. The assay was initiated by the addition of 2 µl of
either 90 nM or 9 nM GST–PDK1 in Buffer B containing 1 mg/ml
bovine serum albumin. After incubation for 30 min at 30°C, stage 2 of
the assay was initiated by the addition of 30 µl of a mixture containing
50 mM Tris-HCl pH 7.5, 0.1 mM EGTA, 0.1% (by volume) 2-mercap-
toethanol, 0.1 mM EGTA, 2.5 µM PKI, 1 µM microcystin-LR, 10 mM
Mg(Ac)2, 100 µM [γ-32P]ATP (200–400 cpm/pmol), 100 µM of the
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peptide KKRNRTLTV. After 10 min at 30°C, the reactions were termi-
nated by spotting the reaction mixture onto p81 phosphocellulose
paper. The papers were washed in phosphoric acid and analyzed by
liquid scintillation counting. A control reaction in which GST–p70 S6
kinase was omitted and taken as the blank and was always less than
5% of the activity measured in the presence of GST–p70 S6 kinase.
The basal GST–p70 S6 kinase activity is the activity measured in the
absence of PDK1. One unit (U) of p70 S6 kinase activity was defined
as the phosphorylation of 1 nmol of the peptide KKRNRTLTV in 1 min.
Phosphorylation of GST–p70 S6 kinase by PDK1
The incubations were identical to stage 1 described above except that
[γ-32P]ATP (500–1000 c.p.m./pmol) was used instead of unlabelled
ATP. The reactions were terminated by addition of SDS to 1% (by
mass). The samples were subjected to SDS–polyacrylamide gel elec-
trophoresis on a 7.5% gel; after staining with Coomassie blue, the
bands corresponding to GST–p70 (detected by autoradiography)
were excised and the 32P-radioactivity associated with each band was
quantified.
Mapping the site on GST–p70 S6 kinase phosphorylated by
PDK1
GST–p70 S6 kinase was phosphorylated with PDK1 at a final concen-
tration of 9 nM as above, except that the scale of the reaction was
increased 10-fold. The reaction was stopped by the addition of SDS
and 2-mercaptoethanol to final concentrations of 1% (by mass) and
1% (by volume), respectively, and heated for 5 min at 95°C. After
cooling, 4-vinylpyridine was added to a concentration of 2.5% (by
volume) and the sample was shaken for 1 h at 30°C, subjected to elec-
tophoresis on a 7.5% SDS–polyacrylamide gel and the 83 kDa 32P-
labelled band corresponding to GST–p70 S6 kinase was excised.
After extraction into SDS, the protein was precipitated with
trichloroacetic acid, washed extensively, and digested at 30°C in 0.3 ml
of 50 mM Tris-HCl pH 8.0, 0.1% (by volume) Triton-X100 containing
2 µg alkylated trypsin. After 16 h, guanidinium hydrochloride was
added on ice to a final concentration to 1.0 M; after centrifugation, the
supernatants, containing 90% of the 32P-radioactivity, were chro-
matographed on a Vydac C18 column as described in the legend to
Figure 5.
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